A detailed history of Tower Research Capital LLC (Trc) transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,983 shares of ABCL stock, worth $46,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,983
Previous 10,780 48.27%
Holding current value
$46,670
Previous $31,000 32.26%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.39 - $3.49 $12,435 - $18,158
5,203 Added 48.27%
15,983 $41,000
Q2 2024

Aug 13, 2024

BUY
$2.73 - $4.73 $17,488 - $30,300
6,406 Added 146.46%
10,780 $31,000
Q1 2024

May 15, 2024

SELL
$4.29 - $5.97 $8,198 - $11,408
-1,911 Reduced 30.41%
4,374 $19,000
Q4 2023

Feb 13, 2024

SELL
$3.91 - $5.93 $8,547 - $12,962
-2,186 Reduced 25.81%
6,285 $35,000
Q3 2023

Nov 14, 2023

SELL
$4.6 - $7.95 $184,349 - $318,604
-40,076 Reduced 82.55%
8,471 $38,000
Q2 2023

Aug 14, 2023

BUY
$5.66 - $7.59 $244,285 - $327,584
43,160 Added 801.19%
48,547 $313,000
Q1 2023

May 09, 2023

SELL
$7.31 - $11.18 $63,977 - $97,847
-8,752 Reduced 61.9%
5,387 $41,000
Q4 2022

Feb 10, 2023

SELL
$9.48 - $14.52 $14,703 - $22,520
-1,551 Reduced 9.89%
14,139 $143,000
Q3 2022

Nov 10, 2022

BUY
$9.2 - $13.68 $92 - $136
10 Added 0.06%
15,690 $155,000
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $80,783 - $150,409
14,123 Added 907.06%
15,680 $167,000
Q1 2022

May 12, 2022

BUY
$7.46 - $14.14 $5,632 - $10,675
755 Added 94.14%
1,557 $15,000
Q4 2021

Feb 14, 2022

SELL
$12.99 - $17.73 $8,859 - $12,091
-682 Reduced 45.96%
802 $12,000
Q3 2021

Nov 15, 2021

BUY
$14.85 - $21.34 $21,027 - $30,217
1,416 Added 2082.35%
1,484 $30,000
Q2 2021

Aug 16, 2021

SELL
$20.19 - $34.17 $68,565 - $116,041
-3,396 Reduced 98.04%
68 $1,000
Q1 2021

May 17, 2021

BUY
$23.29 - $53.2 $72,431 - $165,452
3,110 Added 878.53%
3,464 $118,000
Q4 2020

Feb 16, 2021

BUY
$39.0 - $58.9 $13,806 - $20,850
354 New
354 $14,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.